[Dyslipidemia in renal failure]

Nihon Rinsho. 2004 Jun:62 Suppl 6:118-23.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Arteriosclerosis / etiology
  • Cerebrovascular Disorders / etiology
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Clofibrate / therapeutic use
  • Coronary Disease / etiology
  • Eicosapentaenoic Acid / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / etiology*
  • Hypolipidemic Agents / therapeutic use
  • Kidney Failure, Chronic / complications*
  • Lipoproteins, VLDL / blood
  • Niceritrol / therapeutic use
  • Peripheral Vascular Diseases / etiology
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects
  • Renal Dialysis / adverse effects*
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Lipoproteins, VLDL
  • Triglycerides
  • very low density lipoprotein triglyceride
  • Eicosapentaenoic Acid
  • Niceritrol
  • Clofibrate